Research and Reports

Abstracts

Impact of 1q21 gain and amplification on daratumumab-treated multiple myeloma patients: real-world data from the Australia-New Zealand and Asia-Pacific Myeloma and related diseases registries

Author(s): Kenneth C J Lim, Cameron Wellard, Elizabeth Moore, Slavisa Ninkovic, Wee-Joo Chng, Andrew Spencer, Peter Mollee, Jay Hocking, Phoebe Joy Ho, Wojt Janowski, Kihyun Kim, Karen Dun, Zoe K McQuilten, Fiona Chen, Hang Quach
American Society of Hematology. Abstract URL
Published: 2023

A prospective, multinational study of clinical and biological factors associated with short overall survival in multiple myeloma

Author(s): Andy Tang, Kihyun Kim, Fiona Chen, Zoe K McQuilten, Peter Mollee, Rajeev Rajagopal, Hang Quach, Pheobe Joy Ho, Simon J Harrison, Andrew Spencer, Wee-Joo Chng.
American Society of Hematology. Abstract URL
Published: 2023

How does treatment intolerance affect survival in patients with Multiple Myeloma (MM)?

Author(s): Maryam Alomran, Cameron Wellard, Pin-Yen Chen, Elizabeth M. Moore, Wee Joo Chng.
American Society of Hematology. Abstract URL
Published: 2022

Real world experience of induction therapy for treatment of newly diagnosed multiple myeloma: an analysis from the Australian and New Zealand, and Asia-Pacific Myeloma and related diseases registries.

Author(s): Justin Ng, Elizabeth Moore, Pin-Yen Chen, Cameron Wellard, Peter Mollee, Rajeev Rajagopal, Hang Quach, Jian Hou, Jin Lu, Je-Jung Lee, Kihyun Kim, Wee Joo Chng, Andrew Spencer, on behalf of ANZ and APAC investigators.
International Myeloma Society’s Abstract eBook 2022 (page 159). Abstract URL
Published: 2022
Poster Presentation: Justin Ng IMS poster presentation

VARIATION IN USE OF IMMUNOGLOBULIN AND IMPACT ON SURVIVAL IN MULTIPLE MYELOMA: A REPORT FROM THE AUSTRALIA/NEW ZEALAND (ANZ) AND ASIA-PACIFIC (APAC) MYELOMA AND RELATED DISEASES REGISTRIES (MRDR)

Author(s): Khai Li Chai, Cameron Wellard, Naomi Aoki, Elizabeth M. Moore, Bradley Augustson, Akshay Bapat, Hilary Anne Blacklock, Wee Joo Chng, Rachel Cooke, Cecily Forsyth, Nada Hamad, Simon J. Harrison, Phoebe Joy Ho, Jay Hocking, Ian H. Kerridge, Jin Seok Kim, Kihyun Kim, Tracy King, Georgia J. McCaughan, Peter Mollee, C. Orla Morrissey, Nicholas Murphy, Hang Quach, Xuan Ni Tan, Allison Tso, Kimberly Wong, Andrew Spencer, Erica M. Wood, Zoe K. McQuilten.
EHA Library. Abstract URL
Published: 2022

The Asia-Pacific Myeloma and Related Diseases Registry: Preliminary Results of Real-World Treatment Patterns and Clinical Outcomes

Author(s): Kim Huynh, Naomi Aoki, Kihyun Kim, Wee Joo Chng, Gin Gin Gan, Chang-Ki Min, Je-Jung Lee, Yeow Tee Goh, Cameron Wellard, Zoe McQuilten, Elizabeth M. Moore, Erica M. Wood, Andrew Spencer.
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
DOI: https://doi.org/10.1182/blood-2020-136896
Published: 2020

Real-World Treatment Patterns and Clinical Outcomes in Multiple Myeloma in The Asia-Pacific Region: Preliminary Results of The Asia-Pacific Myeloma and Related Diseases Registry.

Author(s): Naomi Aoki, Elizabeth Moore, Cameron Wellard, Erica Wood, Zoe McQuilten, Kihyun Kim, Yeow Tee Goh, Chang-Ki Min, Je-Jung Lee, Wee Joo Chng, Andrew Spencer.
Journal: EHA Library
Abstract URL: Abstract URL
Published: 2020

Real-World Treatment Patterns and Clinical Outcomes in Multiple Myeloma in the Asia-Pacific Region: Methodology and Preliminary Results of the Asia-Pacific Myeloma and Related Diseases Registry (APAC MRDR).

Author(s): Naomi Aoki, Elizabeth M. Moore, Erica M. Wood, Zoe McQuilten, Cameron Wellard, Andrew Spencer.

Publications

Coming soon.

Reports

Snapshot Data Report

The Asia-Pacific MRDR and Australian and New Zealand MRDR release a joint annual snapshot data report, which provides an interesting comparison between the regions. You can view current and previous reports below:

2023 Data Report

2022 Data Report

Progress Overview – March 2024